CTX-M expression and selection of ertapenem resistance in Klebsiella pneumoniae and Escherichia coli

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 2, 2009, Pages 832-834

  Girlich, Delphine ^a   Poirel, Laurent ^a   Nordmann, Patrice ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CARBAPENEMASE; ERTAPENEM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CONTROLLED STUDY; CTX M 15 GENE; CTX M 2 GENE; CTX M 3 GENE; CTX M 9 GENE; CTX M GENE; DRUG SENSITIVITY; ENZYME ACTIVITY; ESCHERICHIA COLI; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; WILD TYPE;

ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; BETA-LACTAMASES; BETA-LACTAMS; DNA PRIMERS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MUTATION;

EID: 59749084675     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01007-08     Document Type: Article

References (21)

1. Cornaglia, G., K. Russell, G. Satta, and R. Fontana. 1995. Relative importances of outer membrane permeability and group 1 beta-lactamase as determinants of meropenem and imipenem activities against Enterobacter cloacae. Antimicrob. Agents Chemother. 39:350-355.
2. Elliott, E., A. J. Brink, J. van Greune, Z. Els, N. Woodford, J. Turton, M. Warner, and D. M. Livermore. 2006. In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum β-lactamase. Clin. Infect. Dis. 42(11):e95-e98.
3. Fey, A., S. Eichler, S. Flavier, R. Christen, M. G. Höfle, and C. A. Guzmán. 2004. Establishment of a real-time PCR-based approach for accurate quantification of bacterial RNA targets in water, using Salmonella as a model organism. Appl. Environ. Microbiol. 70:3618-3623.
4. Girlich, D., L. Poirel, and P. Nordmann. 2008. Do CTX-M beta-lactamases hydrolyse ertapenem? J. Antimicrob. Chemother. 62:1155-1156.
5. Jacoby, G. A., D. M. Mills, and N. Chow. 2004. Role of β-lactamases and porins in resistance to ertapenem and other β-lactams in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48:3203-3206.
6. CTX-M-3 in hyper-mutable Escherichia coli. Clin. Microbiol. Infect. 12:803-806.
7. Lartigue, M. F., L. Poirel, C. Poyart, H. Réglier-Poupet, and P. Nordmann. 2007. Ertapenem resistance of Escherichia coli. Emerg. Infect. Dis. 13:315-317.
8. DHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases. J. Antimicrob. Chemother. 60:410-413.
9. Livermore, D. M., K. J. Oakton, M. W. Carter, and M. Warner. 2001. Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent β-lactamases. Antimicrob. Agents Chemother. 45:2831-2837.
10. Maillet, S., T. Naas, S. Crepin, A. M. Roque-Afonso, F. Lafay, S. Efstathiou, and M. Labetoulle. 2006. Herpes simplex virus type 1 latently infected neurons differentially express latency-associated and ICP0 transcripts. J. Virol. 80:9310-9321.
11. Mena, A., V. Plasencia, L. García, O. Hidalgo, J. I. Ayestarán, S. Alberti, N. Borrell, J. L. Pérez, and A. Oliver. 2006. Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development. J. Clin. Microbiol. 44:2831-2837.
12. Naas, T., L. Poirel, and P. Nordmann. 2008. Minor extended-spectrum β-lactamases. Clin. Microbiol. Infect. 14:42-52.
13. Nordmann, P., and L. Poirel. 2002. Emerging carbapenemases in Gram-negative aerobes. Clin. Microbiol. Infect. 8:321-331.
14. Poirel, L., M. Gniadkowski, and P. Nordmann. 2002. Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3. J. Antimicrob. Chemother. 50:1031-1034.
15. Poirel, L., C. Héritier, C. Spicq, and P. Nordmann. 2004. In vivo acquisition of high-level resistance to imipenem in Escherichia coli. J. Clin. Microbiol. 42:3831-3833.
16. Raveh, D., A. M. Yinnon, E. Broide, and B. Rudensky. 2007. Susceptibilities of ESBL-producing Enterobacteriaceae to ertapenem, meropenem and piperacillin-tazobactam with and without clavulanic acid. Chemotherapy 53: 185-189.
17. Tamayo, J., B. Orden, J. Cacho, J. Cuadros, J. L. Gomez-Garces, and J. I. Alos. 2007. Activity of ertapenem and other antimicrobials against ESBL-producing enterobacteria isolated from urine in patients from Madrid. Rev. Esp. Quimioter. 20:334-338.
18. Teng, C. P., H. H. Chen, J. Chan, and D. C. Lye. 2007. Ertapenem for the treatment of extended-spectrum beta-lactamase-producing Gram-negative bacterial infections. Int. J. Antimicrob. Agents 30:356-359.
19. Toshima, H., A. Yoshimura, K. Arikawa, A. Hidaka, J. Ogasawara, A. Hase, H. Masaki, and Y. Nishikawa. 2007. Enhancement of Shiga toxin production in enterohemorrhagic Escherichia coli serotype O157:H7 by DNase colicins. Appl. Environ. Microbiol. 73:7582-7588.
20. Walsh, T. R., M. A. Toleman, L. Poirel, and P. Nordmann. 2005. Metallo-beta-lactamases: the quiet before the storm? Clin. Microbiol. Rev. 18:306-325.
21. Welsh, K. J., M. Barlow, F. C. Tenover, J. W. Biddle, J. K. Rasheed, L. A. Clark, and J. E. McGowan, Jr. 2005. Experimental prediction of the evolution of ceftazidime resistance in the CTX-M-2 extended-spectrum β-lactamase. Antimicrob. Agents Chemother. 49:1242-1244.